Page 16 - 《南京医科大学学报》自然科学版2026年第2期
P. 16

第46卷第2期
               ·172 ·                            南 京    医 科 大 学 学         报                        2026年2月


              数据分析和实验操作;李宪琦负责数据收集和处理;王俊宏                             exosome⁃derived microRNA in diabetic heart disease[J].
              与刘新建负责研究指导和论文审阅。                                       Journal of Nanjing Medical University(Natural Sciences),
                  Author’s Contributions:                            2024,44(4):573-578
                  FANG Jiale was responsible for experimental operations,  [11]D’AMATO A,PROSPERI S,SEVERINO P,et al. Mi⁃
              statistical analysis and manuscript writing;ZOU Yu was respon⁃  croRNA and heart failure:a novel promising diagnostic
              sible for data analysis and experimental operations;LI Xianqi  and therapeutic tool[J]. J Clin Med,2024,13(24):7560
              was responsible for data collection and processing;WANG Jun⁃  [12]BOICHENKO V,NOAKES V M,REILLY⁃O’DONNELL
              hong and LIU Xinjian were responsible for research guidance  B,et al. Circulating non⁃coding RNAs as indicators of fi⁃
              and manuscript revision.                               brosis and heart failure severity[J]. Cells,2025,14(7):553
             [参考文献]                                             [13]PARVAN R,BECKER V,HOSSEINPOUR M,et al. Prog⁃
                                                                     nostic and predictive microRNA panels for heart failure
             [1] 中华医学会心血管病学分会,中国医师协会心血管内
                                                                     patients with reduced or preserved ejection fraction:a meta⁃
                   科医师分会,中国医师协会心力衰竭专业委员会,等.
                                                                     analysis of Kaplan⁃Meier⁃based individual patient data[J].
                   中国心力衰竭诊断和治疗指南2024[J]. 中华心血管病
                                                                     BMC Med,2025,23(1):409
                   杂志,2024,52(3):235-275
                                                                [14]REDDY Y N V,CARTER R E,OBOKATA M,et al. A
                   Chinese Society of Cardiology,Chinese Medical Associa⁃
                                                                     simple,evidence⁃based approach to help guide diagnosis
                   tion,Chinese College of Cardiovascular Physician,et al.
                                                                     of heart failure with preserved ejection fraction[J]. Circu⁃
                   Chinese guidelines for the diagnosis and treatment of
                                                                     lation,2018,138(9):861-870
                   heart failure 2024[J]. Chinese Journal of Cardiology,
                                                                [15]DE LUCA M,CRISCI G,ARMENTARO G,et al. Endo⁃
                   2024,52(3):235-275
                                                                     thelial dysfunction and heart failure with preserved ejec⁃
             [2] SHAHIM B,KAPELIOS C J,SAVARESE G,et al. Global
                                                                     tion fraction⁃an updated review of the literature[J]. Life
                   public health burden of heart failure:an updated review  (Basel),2023,14(1):30
                  [J]. Card Fail Rev,2023,9:e11                 [16]PAULUS W J,ZILE M R. From systemic inflammation to
             [3] BORLAUG B A,SHARMA K,SHAH S J,et al. Heart fail⁃
                                                                     myocardial fibrosis:the heart failure with preserved ejec⁃
                   ure with preserved ejection fraction:JACC scientific state⁃
                                                                     tion fraction paradigm revisited[J]. Circ Res,2021,128
                   ment[J]. J Am Coll Cardiol,2023,81(18):1810-1834
                                                                    (10):1451-1467
             [4] MCDONAGH T A,METRA M,ADAMO M,et al. 2021       [17]LI L,BOUNDS K R,CHATTERJEE P,et al. MicroRNA⁃
                   ESC Guidelines for the diagnosis and treatment of acute  130a,a potential antifibrotic target in cardiac fibrosis[J].
                   and chronic heart failure[J]. Eur Heart J,2021,42(36):  J Am Heart Assoc,2017,6(11):e006763
                   3599-3726                                    [18]YAN Y,TIAN L,JIA Q,et al. MiR ⁃ 130a ⁃ 3p regulates
             [5] CANNATA A,MCDONAGH T A. Heart failure with pre⁃     FUNDC1⁃mediated mitophagy by targeting GJA1 in myo⁃
                   served ejection fraction[J]. N Engl J Med,2025,392(2):  cardial ischemia/reperfusion injury[J]. Cell Death Dis⁃
                   173-184                                           cov,2023,9(1):77
             [6] BARTEL D P. MicroRNAs:genomics,biogenesis,mecha⁃  [19]GU M,LIU K,XIONG H,et al. MiR⁃130a⁃3p inhibits en⁃
                   nism,and function[J]. Cell,2004,116(2):281-297    dothelial inflammation by regulating the expression of
             [7] SEIDA M,OGAMI K,YOSHINO S,et al. Fine regulation    MAPK8 in endothelial cells[J]. Heliyon,2024,10(2):
                   of MicroRNAs in gene regulatory networks and pathophys⁃  e24541
                   iology[J]. Int J Mol Sci,2025,26(7):2861     [20]DE GONZALO ⁃ CALVO D,CENARRO A,GARLAS⁃
             [8] CHEN L,KIM V N. Small and long non⁃coding RNAs:     CHELLI K,et al. Translating the microRNA signature of
                   past,present,and future[J]. Cell,2024,187(23):6451-  microvesicles derived from human coronary artery smooth
                   6485                                              muscle cells in patients with familial hypercholesterol⁃
             [9] ZHOU S,JIN J,WANG J,et al. miRNAS in cardiovascu⁃   emia and coronary artery disease[J]. J Mol Cell Cardiol,
                   lar diseases:potential biomarkers,therapeutic targets and  2017,106:55-67
                   challenges[J]. Acta Pharmacol Sin,2018,39(7):1073-  [21]WANG M,WANG X,LIU W. MicroRNA⁃130a⁃3p pro⁃
                   1084                                              motes the proliferation and inhibits the apoptosis of cervi⁃
             [10]孙    玥,周奕廷,丁      栩,等. 外泌体 microRNA 在糖尿             cal cancer cells via negative regulation of RUNX3[J].
                   病性心脏病中的研究进展[J]. 南京医科大学学报(自                        Mol Med Rep,2020,22(4):2990-3000
                   然科学版),2024,44(4):573-578                      (收稿:2025-11-21;修回:2026-01-07;录用:2026-01-07)
                   SUN Y,ZHOU Y T,DING Xu,et al. Research progress of                         (本文编辑:唐       震)
   11   12   13   14   15   16   17   18   19   20   21